Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FWQNM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for 120 tablets of Xtandi 40 mg, an oral oncology medication used in prostate cancer treatment. This firm fixed-price delivery order, issued on September 5, 2025, with a completion date of September 8, 2025, represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, and the place of performance is Park Ridge, Illinois, where the vendor is based.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has maintained a significant role in the federal pharmaceutical supply chain since its SAM.gov registration in 2001. The company holds a substantial single-award IDC with DLA under the SPE2DB program valued at $499,999,999 through November 2026, which authorizes the issuance of delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities. This delivery order for Xtandi exemplifies DMS Pharmaceutical Group's core business of distributing branded prescription medications, generics, biologics, and medical consumables directly to Department of Defense healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FWQNM?
SPE2DB25FWQNM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FWQNM worth?
The government has obligated $4,170 on SPE2DB25FWQNM.
Is contract SPE2DB25FWQNM an order under another contract?
Yes. SPE2DB25FWQNM is a delivery order under SPE2DB25D9307, an indefinite delivery contract.
Was contract SPE2DB25FWQNM competed?
The extent of competition for SPE2DB25FWQNM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award